X

Trial Profile

A Multicenter, Open-label, Phase 1 Study to Evaluate the Safety and Preliminary Efficacy of SOT201 in Patients With Advanced/Metastatic Solid Tumors

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 25 Sep 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SOT 201 (Primary)
Indications Solid tumours
Focus Adverse reactions; First in man
Acronyms VICTORIA-01
Sponsors SOTIO

Most Recent Events

28 May 2024 According to a SOTIO media release, first patient has been dosed in this trial. Additional clinical sites across Europe - including in Belgium, Czech Republic and Spain - will initiate enrollment in the coming months.
24 Apr 2024 Status changed from not yet recruiting to recruiting.
10 Dec 2021 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com